DCVC Bio
Overview
DCVC Bio is a venture capital firm that invests in early-stage deep tech startups in the life sciences. It is the life sciences-focused investment arm of the parent firm, DCVC (Data Collective). The firm's strategy is to invest in scientific breakthroughs and computation-enhanced platforms that can generate new arrays of treatments or products, rather than investing in specific drugs or molecules. Its focus areas include therapeutics platforms, companies improving agriculture and food systems, and industrial biotechnologies that unify data and leverage artificial intelligence and automation. DCVC Bio was co-founded in 2018 by DCVC founders Matt Ocko and Zachary Bogue, along with Dr. John Hamer and Dr. Kiersten Stead.
Portfolio Companies
36
Website
dcvc.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Syntax Bio | Jun 2026 | Series A | Co-investor |
| Latus Bio | May 2026 | Series A | Lead |
| Sidewinder Therapeutics | Apr 2026 | Series B | Co-investor |
| Sidewinder | Apr 2026 | Series B | Co-investor |
| AgZen | Mar 2026 | Series B | Lead |
Key People
Zachary Bogue
Co-Founder and Co-Managing Partner
John Hamer
Managing Partner, DCVC Bio
Kiersten Stead
Managing Partner, DCVC Bio
Matt Ocko
Co-Managing Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
